Brain atrophy after bone marrow transplantation for treatment of multiple sclerosis

B2 Cell-based assays of CAG repeat instability in the huntingtin (HTT) gene

(2016) Tom Massey et al.   JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY

Correlation between brain volume change and T2 relaxation time induced by dehydration and rehydration: Implications for monitoring atrophy in clinical studies

(2014) Kunio Nakamura et al.   NeuroImage-Clinical

Frontal gray matter reduction after breast cancer chemotherapy and association with executive symptoms: A replication and extension study

(2012) Brenna C. McDonald et al.   BRAIN BEHAVIOR AND IMMUNITY

Global and focal brain volume in long-term breast cancer survivors exposed to adjuvant chemotherapy

(2011) Vincent Koppelmans et al.   BREAST CANCER RESEARCH AND TREATMENT

Late effects of high-dose adjuvant chemotherapy on white and gray matter in breast cancer survivors: Converging results from multimodal magnetic resonance imaging

(2011) Michiel B. de Ruiter et al.   HUMAN BRAIN MAPPING

Evidence for acute neurotoxicity after chemotherapy

(2010) Axel Petzold et al.   ANNALS OF NEUROLOGY

Hematopoietic SCT for the treatment of multiple sclerosis

(2010) H Atkins   BONE MARROW TRANSPLANTATION

Gray matter reduction associated with systemic chemotherapy for breast cancer: a prospective MRI study

(2010) Brenna C. McDonald et al.   BREAST CANCER RESEARCH AND TREATMENT

Assessing brain atrophy rates in a large population of untreated multiple sclerosis subtypes

(2010) N. De Stefano et al.   NEUROLOGY

The relation between inflammation and neurodegeneration in multiple sclerosis brains

(2009) Josa M. Frischer et al.   BRAIN

A Primer in Longitudinal Data Analysis

(2008) Garrett M. Fitzmaurice et al.   CIRCULATION

Clinical Patterns and Biological Correlates of Cognitive Dysfunction Associated with Cancer Therapy

(2008) J. Dietrich et al.   ONCOLOGIST